BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9792089)

  • 1. Dialysis: a 5-year perspective.
    Henderson LW
    Adv Ren Replace Ther; 1998 Oct; 5(4):333-40. PubMed ID: 9792089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis in the 21st century.
    Henderson LW
    Am J Kidney Dis; 1996 Dec; 28(6):951-7. PubMed ID: 8957052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future developments in the treatment of end-stage renal disease: a North American perspective.
    Henderson LW
    Am J Kidney Dis; 2000 Apr; 35(4 Suppl 1):S106-16. PubMed ID: 10766009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESRD modality selection into the 21st century: the importance of non medical factors.
    Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
    ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
    [No Abstract]   [Full Text] [Related]  

  • 6. Peritoneal Dialysis or Hemodialysis: Present and Future Trends in the United States.
    Kaplan AA
    Contrib Nephrol; 2017; 189():61-64. PubMed ID: 27951550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-care economics and peritoneal dialysis.
    Nissenson AR
    Perit Dial Int; 1996; 16 Suppl 1():S373-7. PubMed ID: 8728226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making peritoneal dialysis and home hemodialysis more economically viable.
    Sullivan JD
    Nephrol News Issues; 2006 Jul; 20(8):54, 56-8. PubMed ID: 16859233
    [No Abstract]   [Full Text] [Related]  

  • 10. Where we come from and where we are going in terms of peritoneal dialysis: identifying barriers and strategies for the future.
    Moreiras-Plaza MM
    Nefrologia; 2014 Nov; 34(6):756-67. PubMed ID: 25415576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing Landscape for Peritoneal Dialysis: Optimizing Utilization.
    Schreiber MJ
    Semin Dial; 2017 Mar; 30(2):149-157. PubMed ID: 28144977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).
    Brunelli SM; Monda KL; Burkart JM; Gitlin M; Neumann PJ; Park GS; Symonian-Silver M; Yue S; Bradbury BD; Rubin RJ
    Am J Kidney Dis; 2013 Jun; 61(6):947-56. PubMed ID: 23332991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking peritoneal dialysis beyond the year 2000.
    Gokal R
    Perit Dial Int; 1999; 19 Suppl 3():S35-42; discussion S43. PubMed ID: 10433550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
    Hörl WH; de Alvaro F; Williams PF
    Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A; Eshaghian A; Taheri D; Dolatkhah S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home dialysis gets the spotlight--will it help?
    Neumann ME
    Nephrol News Issues; 2016 Apr; 30(4):8, 10. PubMed ID: 27254896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.